MTOR and Hypertension: No correlation was found between ps-NA titers following the fourth dose and age, sex, comorbidities (diabetes mellitus, hypertension, dyslipidemia, and impaired renal function), or subtypes of immunosuppression treatment (MMF, mTOR, or prednisone).